Li Min, Yun Wingyan, Wang Guibin, Li Anqi, Gao Jing, He Qingyong
Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Clinical Department of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Front Pharmacol. 2022 Oct 3;13:954938. doi: 10.3389/fphar.2022.954938. eCollection 2022.
The prevention and treatment of cardiovascular diseases (CVDs) have achieved initial results, but the number of CVDs patients will increase rapidly in the next 10 years. Atherosclerosis (AS) is a significant risk factor for CVDs. The impact of lifestyle and daily diet varies considerably between different countries and continents and has been shown to affect the development of various diseases such as diabetes and CVDs. Primary and secondary prevention using alternative supplements and methods to avoid or reduce the use of traditional pharmacological drugs have also become popular. One of the reasons for this is that pharmacological drugs with lipid-lowering, and blood pressure-lowering effects cause many side effects that may negatively impact the quality of life. Patients are now emphasizing reliance on lifestyle changes to reduce cardiovascular risks. Garlic is a medicinal and edible plant that has been used for a long time. In order to reveal garlic application in the prevention and treatment of AS, reviewing the latest domestic and international studies through searching databases. The result shows that the antiatherogenic role of garlic is eximious. And the mechanisms are mainly related to hypolipidemic, antioxidant, antithrombotic, inhibiting angiogenesis, protecting endothelial cells, anti-inflammatory, anti-apoptotic, inhibiting vascular smooth muscle proliferation, and regulating gut microbiota. The main signaling pathways involve AMPK/TLRs, Keap1/Nrf2, PI3K/AKT, PPARγ/LXRα, GEF-H1/RhoA/Rac, etc. The antiatherogenic actions and molecular mechanism of garlic were reviewed in this study to obtain a robust evidence basis for the clinical application and mechanistic study and provide a theoretical basis for further utilization of garlic.
心血管疾病(CVDs)的防治已取得初步成效,但未来10年CVDs患者数量将迅速增加。动脉粥样硬化(AS)是CVDs的一个重要危险因素。生活方式和日常饮食的影响在不同国家和大洲之间差异很大,并且已被证明会影响糖尿病和CVDs等各种疾病的发展。使用替代补充剂和方法进行一级和二级预防以避免或减少传统药物的使用也变得流行起来。原因之一是具有降脂和降压作用的药物会引起许多副作用,可能对生活质量产生负面影响。患者现在强调依靠生活方式的改变来降低心血管风险。大蒜是一种长期使用的药食两用植物。为揭示大蒜在AS防治中的应用,通过检索数据库回顾国内外最新研究。结果表明,大蒜的抗动脉粥样硬化作用显著。其机制主要与降血脂、抗氧化、抗血栓形成、抑制血管生成、保护内皮细胞、抗炎、抗凋亡、抑制血管平滑肌增殖以及调节肠道微生物群有关。主要信号通路涉及AMPK/TLRs、Keap1/Nrf2、PI3K/AKT、PPARγ/LXRα、GEF-H1/RhoA/Rac等。本研究对大蒜的抗动脉粥样硬化作用及其分子机制进行了综述,为临床应用和机制研究提供有力的证据基础,并为大蒜的进一步利用提供理论依据。